{
    "eid": "2-s2.0-85085663952",
    "title": "BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients",
    "cover-date": "2020-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Obstetrics and Gynecology",
            "@code": "2729",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "BRCA mutation",
        "Immunohistochemistry",
        "Ovarian cancer"
    ],
    "authors": [
        "Tarinee Manchana",
        "Patou Tantbirojn",
        "Natkrita Pohthipornthawat"
    ],
    "citedby-count": 3,
    "ref-count": 21,
    "ref-list": [
        "Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review",
        "Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer",
        "Integrated genomic analyses of ovarian carcinoma",
        "BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer",
        "BRCA immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas",
        "The Prognostic value of BRCA1 and PARP expression in epithelial ovarian carcinoma: Immunohistochemical detection",
        "Homologous recombination deficiency and ovarian cancer",
        "BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study",
        "BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing",
        "Survival outcomes for different subtypes of epithelial ovarian cancer",
        "BRCA mutation in high grade epithelial ovarian cancers",
        "Germline mutations in Thai patients with non-mucinous epithelial ovarian cancer",
        "The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer",
        "BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer",
        "Inherited mutations in women with ovarian carcinoma",
        "Identification of BRCA1-deficient ovarian cancers",
        "The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis",
        "BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group Study",
        "Current role of poly(ADP-ribose) polymerase inhibitors: which poly(ADP-ribose) polymerase inhibitor and when?",
        "Familial breast/ovarian cancer and BRCA1/2 genetic screening: the role of immunohistochemistry as an additional method in the selection of patients",
        "Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60022183",
        "affilname": "King Chulalongkorn Memorial Hospital",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "RatchadapisekSompoch Fund",
        "Chulalongkorn University"
    ]
}